A growing body of literature suggests that the ubiquitously expressed Src family kinases (Src, Fyn and Yes) are required for agents such as platelet-derived growth factor (PDGF) to stimulate DNA synthesis. Yet Klinghoer and colleagues recently presented evidence that ®broblasts derived from mice null for Src, Fyn and Yes responded normally to PDGF (Klinghoer et al., 1999 , EMBO J., 18: 2459 ± 2471 . What is the reason for this discrepancy? We noted that Klinghoer et al. (1999) used SV40 large T antigen (largeT) to facilitate derivation of cell lines from the embryos. We therefore tested the eect of largeT on PDGF receptor signaling. We found that expression of largeT overcame the inhibitory eects of interfering forms of both Ras (N17Ras) and Src (SrcK7). Furthermore, injection of SrcK7 or the cst.1 antibody (which inhibits Src, Fyn and Yes) failed to inhibit PDGF-stimulated DNA synthesis in NIH3T3 cells expressing dominant negative p53, and ®broblasts derived from p53 null embryos. These data suggest ®rstly that caution should be used in interpretation of experiments conducted in cell lines expressing largeT, and secondly that the role of Src family kinases in growth factor signaling may be to oppose the eects of negative growth regulators such as p53. Oncogene (2000) 19, 2867 ± 2869.
Keywords: p53; PDGF; mitogenesis; Src Klinghoer et al. (1999) recently characterized embryos de®cient in the three ubiquitously expressed members of the Src family, Src Fyn and Yes. Lack of these three tyrosine kinases results in early embryonic lethality; nevertheless they were able to isolate ®broblast cell lines (SFY cells) for more detailed biochemical analyses. Their main conclusions were that integrin responses and motility were severely hampered in SFY cells, but DNA synthesis in response to PDGF occurred normally. There is a discrepancy between these data and several papers in the literature in which expression of dominant negative forms of Src family kinases and neutralizing antibodies have been described to inhibit PDGF-stimulated DNA synthesis (Barone and Courtneidge, 1995; Broome and Hunter, 1996; Erpel et al., 1996; Twamley-Stein et al., 1993) . Various explanations have been posited for this discrepancy (Klinghoer et al., 1999) . For example the SFY cells may contain other members of the Src family that compensate for the lack of the three usually expressed in ®broblasts, or other signaling pathways may have been upregulated in compensation. However, we ®rst considered that the SV40 large T antigen (largeT) Klinghoer et al used to generate the cell lines might provide an explanation, especially since others have shown that expression of largeT can drive quiescent cells into the cell cycle (Dickmanns et al., 1994) .
We ®rst tested what eect largeT expression would have on the ability of two dierent proteins to interfere with PDGF-stimulated DNA synthesis in NIH3T3 cells. Figure 1 shows that whereas N17Ras and SrcK7 showed the expected inhibition when injected alone, they did not inhibit when co-injected with largeT. Note that the amount of largeT being expressed was insucient to drive DNA synthesis in the absence of PDGF. This suggests that even though Src and Ras signaling pathways are no longer necessary, there must be at least one signaling event initiated by PDGF for Oncogene (2000) 19, 2867 ± 2869 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc Figure 1 Expression of SV40 large T antigen eliminates the need for Src and Ras signaling pathways. NIH3T3 mouse ®broblasts on gridded glass coverslips (Eppendorf) were serum-starved for 28 h in Dulbecco's modi®ed Eagle's medium containing 0.5% fetal bovine serum, followed by plasmid DNA microinjection as described in . Src and Ras plasmids were at 50 mg/ml, SV40 large T was at 5 mg/ml. Following a 14 h incubation, cells were stimulated with PDGF BB (20 ng/ml), labeled with 30 mM BrdU, and incubated a further 18 h. Cells were ®xed in methanol/acetone (1 : 1) and stained for Src or Ras expression by indirect immuno¯uorescence staining with monoclonal antibodies to Src or Ras (Calbiochem) followed by goat anti-mouse Texas Red conjugated secondary antibody (Molecular Probes). BrdU incorporation was detected by Anti-BrdU-FITC (Roche Biochemicals) ) was originally made using largeT (Soriano et al., 1991) . While this is dicult to reconcile with the data presented here, we note that for these experiments the cells were selected using G418, even though the Src 7/7 cells were originally both largeT expressing and G418 resistant. We speculate that at some point during passage, the starting cell line may have lost, or reduced, expression of both the selectable marker and largeT.
LargeT, the transforming protein of the DNA tumor virus SV40, is known to associate with several cellular proteins in order to achieve its immortalization and transformation eects. The most characterized interactions are those that inactivate the products of two tumor suppressor genes, Rb and p53 (DeCaprio et al., 1988; Lane and Crawford, 1979; Levine and Momand, 1990) . Can the lack of requirement for Src family kinase signaling in cells expressing largeT be attributed to the functional loss of one or both of these proteins? Preliminary experiments (unpublished) suggested that ®broblasts lacking Rb still required Src family kinases. To ask about a possible p53 requirement, we microinjected cells with a dominant interfering form of p53. This protein still contains the DNA binding 7/7 mouse embryos (Weber et al., 1999) were microinjected with 50 mg/ml Src plasmids as described in Figure 1 . Expressing cells were detected by indirect immuno¯uorescence staining with a monoclonal antibody to Src as described in Figure 1 . Detection of BrdU incorporation and data analysis was as described in 7/7 mouse embryo ®broblasts. Quiescent primary ®broblasts as in (c) were microinjected with 50 mg/ml RasN17 plasmid as described in Figure 1 or IgG (control rabbit nonimmune or cst.1). Expressing cells were detected by indirect immuno¯uorescence staining with a monoclonal antibody to Ras as described in Figure 1 . IgG containing cells were detected by immuno¯uorescence staining with goat anti-rabbit Texas Red conjugated secondary antibody (Molecular Probes). Detection of BrdU incorporation and data analysis was as described in Figure 1 . Data are from three separate experiments with a total of approximately 200 expressing cells for each plasmid and tetramerization sequences, but it lacks the amino terminal 71 amino acids that comprise the transactivation domain (Figure 2a ), and interferes with wild type p53 function as measured in a variety of assays (J Bischo, personal communication) . Figure 2b shows that expression of this interfering form of p53 rescued the block caused by SrcK7. Interestingly, the block caused by N17Ras could not be overcome by dominant negative p53, suggesting that these two proteins lie on dierent pathways.
These data strongly suggest that Src family kinases act to oppose negative growth regulators such as p53, and therefore that Src family kinase signaling might be unnecessary in ®broblasts that are de®cient in p53. To test this, we compared primary mouse embryo ®broblasts derived from wild type and p53 de®cient embryos (Figure 2c,d) . The wild type ®broblasts, like their established counterparts such as NIH3T3, required Src family kinases in order for PDGF to induce DNA synthesis, as determined by inhibition of DNA synthesis by SrcK7 and the cst.1 antibody (which inhibits Src, Fyn and Yes). In contrast, both SrcK7 and anti-cst.1 failed to inhibit in p53 7/7 cells (Figure 2c,d) .
Much recent attention has focused on the role of p53 in the response to DNA damage. However, p53 is also present at low levels in growing cells, and many DNA tumor viruses encode proteins that inactivate p53 by direct association or ubiquitination-mediated degradation, presumably to facilitate entry of cells into cycle, and therefore viral replication (reviewed in Oren, 1999; Prives and Hall, 1999) . However one DNA tumor virus, polyoma, does not appear to use this strategy; the large T antigen of polyomavirus, unlike its SV40 homologue, does not associate with p53, nor does p53 appear to be degraded in polyomavirus-infected cells (Dilworth, 1990) . It is interesting to speculate that polyomavirus uses its middle T antigen, which associates with and activates Src and Yes, to inhibit the function of p53. These data further suggest that inactivation (or neutralization) of p53, via an as yet unde®ned biochemical pathway, may be an important component of the normal response of cells to growth factors, as suggested by Oren (1999) . We are currently searching for possible components of such a pathway.
We conclude that SV40 large T antigen can bypass the requirements for several signals emanating from growth factor receptors, and that its ability to inactivate p53 may obviate a need for Src family kinases. These ®ndings have implications for the study of signaling pathways in cell lines, and perhaps also for the use of signal transduction inhibitors in human cancers where negative regulators such as p53 are frequently mutated or absent.
